Table 6.

Antibiotic use for the top ten diagnoses among inpatients, by ATC classification

Diagnosis	LRTI		SST		Proph OBGY		Neo-MP		GI		HIV		OBGY		Sepsis		CNS		BJ		Total
Antibiotic ATC classes	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	n	%	N	%
Aminoglycosides	4	3.8	4	4.5	0	0.0	16	50.0	3	12.5	0	0.0	0	0.0	2	11.1	1	8.3	0	0.0	30	7.9
Beta-lactam combination penicillin	34	32.7	27	30.3	1	1.9	0	0.0	3	12.5	0	0.0	2	11.1	3	16.7	0	0.0	1	9.1	71	18.7
Carbapenems	1	1.0	2	2.2	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	8	44.4	1	8.3	0	0.0	12	3.2
Glycopeptides	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	2	11.1	1	8.3	0	0.0	3	0.8
Imidazoles	12	11.5	24	27.0	26	49.1	0	0.0	13	54.2	0	0.0	8	44.4	1	5.6	0	0.0	2	18.2	86	22.7
Macrolides	14	13.5	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	5.6	0	0.0	0	0.0	0	0.0	15	4.0
Oxazolidinones	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	0	0.0	1	8.3	0	0.0	1	0.3
Extended spectrum penicillins	8	7.7	10	11.2	22	41.5	16	50.0	3	12.5	0	0.0	4	22.2	0	0.0	0	0.0	5	45.5	68	17.9
Sulphonamide-trimethoprim combination	1	1.0	0	0.0	0	0.0	0	0.0	0	0.0	18	100.0	0	0.0	0	0.0	0	0.0	0	0.0	19	5.0
3GCs	30	28.8	22	24.7	4	7.5	0	0.0	2	8.3	0	0.0	3	16.7	2	11.1	8	66.7	3	27.3	74	19.5
Total	104	100.0	89	100.0	53	100.0	32	100.0	24	100.0	18	100.0	18	100.0	18	100.0	12	100.0	11	100.0	379	100.0

3GC third-generation cephalosporin, ATC Anatomical Therapeutic Chemical, BJ bone and joint, CNS central nervous system, GI gastrointestinal, HIV human immunodeficiency virus, LRTI lower respiratory tract infection, Neo-MP neonatal medical prophylaxis, OBGY obstetrics and gynaecology, Proph OBGY prophylaxis obstetrics and gynaecology, SST skin and soft tissue, n frequency, N Population